News|Articles|April 29, 2024
Integrated Capabilities for Aseptic Injectable Fill-Finish
Author(s)Kindeva
Our facility in Bridgeton, MO, delivers Annex 1 compliance with every line. Along with our other facilities in the St. Louis area, this site makes us one of only a few CDMOs capable of servicing sterile fill, device manufacture, and final assembly in one geographic location. This saves you time and money while reducing your carbon footprint.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
5